| Sign In to gain access to subscriptions and/or personal tools. |
An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly populationNational Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia
School of Medicine and Pharmacology, University of Western, Perth, Australia
School of Medicine and Pharmacology, University of Western, Perth, Australia
Cognitive Drug Research Ltd, Goring-on-Thames UK
National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia
National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia
National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia
National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia
National Institute of Complementary Medicine (NICM) - Collaborative Centre for the Study of Natural Medicines and Neurocognition in Health and Disease, Brain Sciences Institute, Swinburne University of Technology, Hawthorn, Australia, cstough{at}swin.edu.au The study examines the effects of the antioxidant flavonoid Pycnogenol on a range of cognitive and biochemical measures in healthy elderly individuals. The study used a double-blind, placebo-controlled, matched-pair design, with 101 elderly participants (60—85 years) consuming a daily dose of 150 mg of Pycnogenol for a three-month treatment period. Participants were assessed at baseline, then at 1, 2, and 3 months of the treatment. The control (placebo) and Pycnogenol groups were matched by age, sex, body mass index, micronutrient intake, and intelligence. The cognitive tasks comprised measures of attention, working memory, episodic memory, and psychomotor performance. The biological measures comprised levels of clinical hepatic enzymes, serum lipid profile, human growth hormone, and lipid peroxidation products. Statistically significant interactions were found for memory-based cognitive variables and lipid peroxidation products, with the Pycnogenol group displaying improved working memory and decreased concentrations of F2-isoprostanes relative to the control group.
Key Words: antioxidant aged cognition oxidative stress Pycnogenol
Journal of Psychopharmacology, Vol. 22, No. 5,
553-562 (2008) |
|||